Literature DB >> 12771304

Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland.

Shigeru Yumita1.   

Abstract

There is a significant recurrence rate of secondary (renal) hyperparathyroidism after total parathyroidectomy (PTx) with forearm autograft. The lesions responsible for recurrent hyperparathyroidism are mainly the parathyroid autografts, but in some cases there are previously undetected residual or ectopic parathyroid glands. In Kojinkai hospitals, 155 haemodialysis out-patients had total PTx and forearm autograft for severe renal hyperparathyroidism and, during the past 18 years, 40 of them developed recurrent or persistent renal hyperparathyroidism. Five patients were treated by percutaneous ethanol injection therapy (PEIT): four patients had residual parathyroid glands and one patient had an ectopic parathyroid gland. The results of PEIT depended on the functioning of the parathyroid autografts. In two patients with non-functioning autografts, the effect of PEIT was remarkable; both showed 'hungry bone' syndrome and became hypoparathyroid. In the three patients with functioning autografts, the clinical course after PEIT was mild, but resection of the autograft was required in one patient. When an echo-guided approach is possible, PEIT for residual parathyroid glands is an effective intervention for the management of recurrent renal hyperparathyroidism; however, there is a risk of hypoparathyroidism in patients with non-functioning parathyroid autografts. As parathyroid autografts consist of multiple nodules, echo-guided injection of ethanol or calcitriol to each nodule is almost impossible and therefore resection of the autograft is indicated for autograft-dependent recurrent renal hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771304     DOI: 10.1093/ndt/gfg1016

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Use of 99mTc-sestamibi SPECT/CT imaging in predicting the degree of pathological hyperplasia of the parathyroid gland: semi-quantitative analysis.

Authors:  Junhao Ma; Jun Yang; Chuanzhi Chen; Yimin Lu; Zhuochao Mao; Haohao Wang; Yan Yang; Zhongqi Li; Weibin Wang; Lisong Teng
Journal:  Quant Imaging Med Surg       Date:  2021-10

2.  Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy.

Authors:  Walter G Douthat; Gabriela Cardozo; Gabriela Garay; Santiago Orozco; Carlos Chiurchiu; Jorge de la Fuente; Javier de Arteaga; Pablo U Massari
Journal:  Int J Nephrol       Date:  2011-06-04

3.  Unusual recurrent renal secondary hyperparathyroidism caused by hyperplastic autograft with supernumerary parathyroid adenoma: A case report.

Authors:  Jun Zhang; Meng-Jie Dong; Jun Yang; Dan Tian
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial.

Authors:  Katja Schlosser; Johannes A Veit; Stefan Witte; Emilio Domínguez Fernández; Norbert Victor; Hans-Peter Knaebel; Christoph M Seiler; Matthias Rothmund
Journal:  Trials       Date:  2007-09-18       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.